Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
Overview of attention for article published in New England Journal of Medicine, January 2017
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (99th percentile)
-
High Attention Score compared to outputs of the same age and source (87th percentile)
Mentioned by
- news
- 59 news outlets
- blogs
- 2 blogs
- policy
- 8 policy sources
- 155 X users
- patent
- 38 patents
- 15 Facebook pages
- wikipedia
- 7 Wikipedia pages
- f1000
- 1 research highlight platform
- video
- 1 YouTube creator
- guideline
- 11 clinical guideline sources
- podcasts
- 6 podcasts
Readers on
- mendeley
- 1611 Mendeley
- citeulike
- 1 CiteULike